5.4B, trading at 0.40 on the NYSE. This SniperIQ fundamentals page covers Teva Pharmaceutical Industries's valuation (P/E 22.6x, P/B 4.3x), profitability (net margin 9.0%), revenue (0.40 on the NYSE. Market cap moves with the live share price.

What is Teva Pharmaceutical Industries's P/E ratio?

Teva Pharmaceutical Industries's trailing twelve-month P/E ratio is 22.6x, with a price-to-book (P/B) of 4.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries runs a net profit margin of 9.0%, a gross margin of 52.1%, and an operating margin of 18.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Teva Pharmaceutical Industries generate?

Teva Pharmaceutical Industries reported revenue of